66 -- MicroArray Custom Chips

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. This is a Request for Quotation (RFQ); a written solicitation will not be issued. The Food and Drug intends to negotiate on a sole source basis with Affymetrix, for Custom E. Coli Genechip Microarrays. Submit offers on FDA-SOL-07-00407. This acquisition will be processed under Simplified Acquisition Procedures (SAP) and is not a Small Business Set-Aside. The North American Industry Classification System (NAICS) code for this procurement is 54170 and the small business size is 500. This procurement is a firm fixed price requirement. SCOPE OF WORK - the contractor shall design and construct custom Genechip microarrays to be utilized with an integrated Affymetrix Genechip Scanner 3000 and Fluidics 450s system. The arrays must be high-density probe arrays capable of performing quantitative and simultaneous monitoring of thousands of genes. The arrays must be able to able to accommodate at least 22,000 unique E. Coli genes and 1,000 control sequences (23,000 total probe sets). Each of the gene sequence represented on this array must have 11 perfectly matched 25-mer probes as well as 11 hybridization. This should result in an array capable of accommodating >500,000 individual features. The size of each of these features must be 11 microns. The arrays must contain the following hybridization controls: bioB, bioC, bioD and cre. The arrays must contain a normalization control set of 100 probe sets. FOB point shall be the destination, Laurel, MD. Delivery location is FDA, Muirkirk Road Complex, 8301 Muirkirk Road, Laurel, MD 20708. Interested offeror?s shall submit a descriptive literature along with their cost quotation. This is Request for Quotation (RFQ). APPLICABILITY OF FAR PROVISIONS: the following Federal Acquisition Regulation (FAR) provisions and clauses apply to this solicitation and are incorporated by references. FAR 52.212-1 Instruction to Offerors ? Commercial Items. Offer must include a completed copy of FAR provisions 52.212-3 Offeror Representations and Certifications ? Commercial Items with their offer at website http://orca.bpn.gov. FAR provision 52.232-18 Availability of Funds. FAR Provision 52.212-4 Contract Terms and Conditions - Commercial Items. FAR 52.215-5 Facsimile Quotations. FAR 52.212-5, Contract terms and Conditions Required to Implement Statues or Executive Orders ? Commercial Items, for paragraphs a, b and c, only the following clauses apply to this acquisition: 52.233-3, Protest after Award (31 U.S.C. 3553); 52.203-6, Restrictions on Subcontractor Sales to the Government, with Alternate I (41 U.S.C. 253g and 10 U.S.C. 2402); 52.219-8, Utilization of Small Business Concerns (15 U.S.C. 637(d)(2) and (3)); 52.222-21, Prohibition of Segregated Facilities (FEB 1999); 52.222-26, Equal Opportunity (E. O. 11246); 52.222-35, Affirmative Action for Disabled Veterans and Veterans of the Vietnam Era (38 U.S.C. 4212); 52.222-36, Affirmative Action for Workers with Disabilities (29 U.S.C. 793); 52.222-37, Employment Reports on Disabled Veterans and Veterans of the Vietnam Era (38 U.S.C. 4212); 52.222-19, Child Labor ? Cooperation with Authorities and Remedies (E.O. 13126); 52.225-1, Buy American Act ? Balance of Payments Program ? Supplies (41 U.S.C. 10a-10d) and; 52.232-34, Payment by Electronic Funds Transfer-Other than Central Contractor Registration (31 U.S.C. 3332). Offers are due in this office no later than September 4, 2007. The point of contact for this requirement is Sharon Kindall, telephone (301) 827-0305 and fax number is (301) 827-7106. Submit Offers to the Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, HFA-505, 5630 Fishers Lane, Room 2080, Rockville, MD 20857, Attention Sharon Kindall. An official authorized to bind the Offeror must sign the terms and conditions of the offer. Offerors that fail to finish required representation and certifications, or reject the terms and conditions of the solicitation, may be excluded from consideration. All responsible sources may submit a quote, which shall be considered.